ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,883Medicare Part D Prescriptions Filled, Including Refills

Rank: 188 out of 2035

$428K Total Retail Price of All Prescriptions

Rank: 424 out of 2035

366 Patients Receiving at Least One Drug in Part D
36%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

18% of this provider’s 366 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 3,535 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
LISINOPRIL 518 216 1 3
OMEPRAZOLE 400 155 2 5
SIMVASTATIN 353 151 3 1
METFORMIN HCL 295 136 4 9
AMLODIPINE BESYLATE 261 136 5 6
HYDROCODONE-ACETAMINOPHEN 259 70 S3 6 2
ATENOLOL 240 66 7 10
LEVOTHYROXINE SODIUM 230 91 8 4
TRAMADOL HCL 206 35 9 19
GLIPIZIDE 197 87 10 54
HYDROCHLOROTHIAZIDE 192 99 11 12
METOPROLOL TARTRATE 190 74 12 8
FUROSEMIDE 182 88 13 7
PRAVASTATIN SODIUM 174 79 14 17
PROAIR HFA 170 44 15 31
ZOLPIDEM TARTRATE 169 43 16 21
GABAPENTIN 153 27 17 14
WARFARIN SODIUM 141 38 18 11
POTASSIUM CHLORIDE 137 81 19 18
ALENDRONATE SODIUM 135 103 20 27
AMITRIPTYLINE HCL 117 13 R 21 101
CLONIDINE HCL 115 17 22 61
FLUOXETINE HCL 114 23 23 81
SERTRALINE HCL 113 45 24 23
TRIAMTERENE-HCTZ 113 36 24 35
CARVEDILOL 100 27 26 22
IBUPROFEN 94 0 27 43
SPIRIVA 93 28 28 44
ADVAIR DISKUS 92 30 29 38
RANITIDINE HCL 89 11 30 28
ATORVASTATIN CALCIUM 89 35 30 13
FLUTICASONE PROPIONATE 88 29 32 29
LOSARTAN POTASSIUM 87 39 33 15
BUSPIRONE HCL 84 0 34 176
TRAZODONE HCL 83 13 35 50
CITALOPRAM HBR 83 0 35 20
TAMSULOSIN HCL 77 50 37 25
GLYBURIDE 76 66 R 38 74
GEMFIBROZIL 74 13 39 114
CYCLOBENZAPRINE HCL 72 14 R 40 64
LOVASTATIN 68 29 41 33
METOPROLOL SUCCINATE 68 21 41 16
NORTRIPTYLINE HCL 63 35 43 266
CLOPIDOGREL 60 20 44 30
KLOR-CON M20 59 54 45 73
NEXIUM 59 36 45 51
JANUVIA 58 30 47 85
INSULIN SYRINGE 57 22 48 97
VENTOLIN HFA 57 18 48 80
LANTUS 52 13 50 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.